What amount sold does Arizona Isotopes Science Research Corp. report in Form D filings?

The latest linked filings report $100.5M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Arizona Isotopes Science Research Corp.'s most recent SEC filing?

Arizona Isotopes Science Research Corp.'s most recent Form D filing was on 2024-05-29.

How many investors does Arizona Isotopes Science Research Corp. have?

The most recent Form D filing lists 105 investor(s).

What type of securities does Arizona Isotopes Science Research Corp. offer?

Arizona Isotopes Science Research Corp.'s SEC Form D filings indicate equity offerings.

Arizona Isotopes Science Research Corp.

CIK: 0001742172·Pharmaceuticals·BUNKER HILL, IN·Corporation

Reported Sold

$100,484,480

Total Filings

Identified Offerings

Last Filed

May 29, 2024

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

May 29, 2024Form D/A — Amendment

Reported sold: $58,330,980 · Target: Indefinite

Rule 506(b)·105 investors

Changed: Reported amount sold, Reported investors, Reported revenue range

Aug 7, 2023Form D/A — Amendment

Reported sold: $55,609,500 · Target: Indefinite

Rule 506(b)·98 investors

Changed: Reported amount sold, Reported investors, Reported revenue range

Apr 3, 2023Form D/A — Amendment

Reported sold: $52,013,500 · Target: Indefinite

Rule 506(b)·97 investors

Changed: Reported amount sold, Reported investors

Mar 30, 2023Form D/A — Amendment

Reported sold: $51,988,500 · Target: Indefinite

Rule 506(b)·96 investors

Changed: Reported amount sold, Reported investors

May 26, 2022Form D — New notice

Reported sold: $47,024,500 · Target: Indefinite

Rule 506(b)·89 investors

Jul 6, 2021Form D/A — Amendment

Reported sold: $42,153,500 · Target: Indefinite

Rule 506(b)·85 investors

Changed: Reported amount sold, Reported investors

Aug 24, 2020Form D/A — Amendment

Reported sold: $25,797,000 · Target: Indefinite

Rule 506(b)·55 investors

Changed: Reported amount sold, Offering target, Reported investors

Nov 20, 2019Form D/A — Amendment

Reported sold: $24,400,000 · Target: Indefinite

Rule 506(b)·55 investors

Changed: Reported amount sold, Reported investors

Sep 24, 2019Form D/A — Amendment

Reported sold: $19,800,000 · Target: Indefinite

Rule 506(b)·40 investors

Changed: Reported amount sold, Offering target, Reported investors, Reported revenue range

May 30, 2018Form D — New notice

Reported sold: $15,000,000 · Target: $50,000,000

Rule 506(b)·10 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

105

Revenue Range

$1,000,001 - $5,000,000

Reported commissions across identified offerings

Amendment Rate

80%

Latest reported sold across 2 identified offerings

$100,484,480

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Wesley Brandt Brooksby

Related Person

Appears on 7 filings

Greg W Brooksby

Related Person

Appears on 6 filings

Sheldon L Trubatch

Related Person

Appears on 5 filings

Clyde Peter Jupiter

Related Person

Appears on 5 filings

Patricia Jupiter

Related Person

Appears on 5 filings

George R Parker

Related Person

Appears on 5 filings

Sheldon L Trubatch

Related Person

Appears on 5 filings

Timothy W Morris

Related Person

Appears on 4 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
May 29, 2024	Amendment	Indefinite	$58,330,980	105
Aug 7, 2023	Amendment	Indefinite	$55,609,500	98
Apr 3, 2023	Amendment	Indefinite	$52,013,500	97
Mar 30, 2023	Amendment	Indefinite	$51,988,500	96
May 26, 2022	New	Indefinite	$47,024,500	89
Jul 6, 2021	Amendment	Indefinite	$42,153,500	85
Aug 24, 2020	Amendment	Indefinite	$25,797,000	55
Nov 20, 2019	Amendment	Indefinite	$24,400,000	55
Sep 24, 2019	Amendment	Indefinite	$19,800,000	40
May 30, 2018	New	$50,000,000	$15,000,000	10

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Telemachus Therapeutics, Inc.

Pharmaceuticals

Offering target: $1,500,000

Filed Oct 28, 2026